Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E. Elez Fernandez"'
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept
Autor:
E. Elez Fernandez, A. Fernández Montes, P. García-Alfonso, B. Gonzalez Astorga, A.M. López Muñoz, F Salvà Ballabrera, E. Aranda Aguilar, A. Salud Salvia, R Vera García, E. Gonzalez Flores
Publikováno v:
Scientia
Clinical & Translational Oncology
Clinical & Translational Oncology
Aflibercept; Càncer colorectal; Perfil del pacient Aflibercept; Cáncer colorrectal; Perfil del paciente Aflibercept; Colorectal cancer; Patient profile Colorectal cancer is the second leading cause of cancer-related death worldwide. For metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad75cbfb99fbfba2d763d9d751f96bf
https://link.springer.com/content/pdf/10.1007/s12094-021-02568-y.pdf
https://link.springer.com/content/pdf/10.1007/s12094-021-02568-y.pdf
Autor:
Julien Taieb, E. Elez Fernandez, Axel Grothey, E. Carriere Roussel, M. Van den Eynde, A. Ruiz Casado, Takayuki Yoshino, Z. Issiakhem, J. Vedovato, B. Jean, Evaristo Maiello, Thierry André, T. Kato, E. Van Cutsem, C. Cahuzac, Paul Ross, Janet Graham, Rona Yaeger, J. Ruffinelli, R. Vera, J. Tabernero
Publikováno v:
Annals of Oncology, Vol. 31, no.3, p. S242-S243 (2020)
Background BRAFV600E mutations are identified in 8-15% of metastatic colorectal cancer (mCRC) patients and confer a poor prognosis. In patients with BRAFV600E-mutant mCRC, the combination of encorafenib (ENCO) + cetuximab (CETUX) ± binimetinib (BINI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9692af7497c2a84c8b436e1668999ff9
https://hdl.handle.net/2078.1/273102
https://hdl.handle.net/2078.1/273102
Autor:
Paolo Nuciforo, Iosune Baraibar, J. Tabernero, N. Bayo, Elena Garralda, Alejandro Javier García, Mireia Sanchis, S. Napoli, E. Elez Fernandez, Noelia Sánchez Sánchez, N. Ann Wornham, A. Piris
Publikováno v:
Annals of Oncology. 32:S137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b934da22c4cea7d9e975f830040a016e
https://doi.org/10.1016/j.annonc.2021.05.167
https://doi.org/10.1016/j.annonc.2021.05.167
Autor:
E. Elez Fernandez, Tadamichi Denda, Hiroya Taniguchi, Kiwamu Akagi, J. Tabernero, Yoshito Komatsu, Alejandro Javier García, Jesus Garcia-Foncillas, Yoshinori Kagawa, Takeharu Yamanaka, Eiji Oki, Ana Vivancos, Hiroko Bando, Iosune Baraibar, T. Satoh, D. Ciardiello, Takayuki Yoshino, T. Kato, Javier Ros, Tomohiro Nishina
Publikováno v:
Annals of Oncology. 31:239-240
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fccbe9d77202e2eabe9228002f0d1d85
https://doi.org/10.1016/j.annonc.2020.04.074
https://doi.org/10.1016/j.annonc.2020.04.074
Autor:
Rocio Garcia-Carbonero, B. Martin-Cullell, C. Santos Vivas, F. Losa, E. Elez Fernandez, Mónica Fernández, J. Vidal Barrull, R. Salazar, E. Aranda Aguilar, M. Benavides, J. Tabernero, P. García-Alfonso, Beatriz Bellosillo, Jose Luis Manzano, D. Casadevall, M. Castro-Henriques, R. Ferreiro, V. Alonso-Orduna, C. Montagut Viladot, R. Rodriguez Alonso
Publikováno v:
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background Genotyping of ctDNA characterizes the molecular profile and monitors tumor molecular dynamics, but the clinical applicability of next generation sequencing (NGS) DNA sequencing has not been assessed in a large prospective cohort of mCRC pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8230c5ff0d32412ef65d55f685e4e2
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3128
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3128
Autor:
S. Roselló Keränen, F. Ghiringhelli, J. Tabernero, Andrea Pellacani, Salvatore Siena, Giuseppe Curigliano, Alberto Sobrero, Daniel H. Ahn, E. Elez Fernandez, D. Laurent, Gunnar Folprecht, C. Cremolini, C.J.A. Punt, A. Capriati, M. Ferrara, M. Kwiatek
Publikováno v:
Annals of Oncology. 31:S115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ead0c2d5715f82ad3d3b63de559b9d81
https://doi.org/10.1016/j.annonc.2020.04.161
https://doi.org/10.1016/j.annonc.2020.04.161
Autor:
Jaume Capdevila, Elena Garralda, M. Sanso, Rodrigo Dienstmann, Joan Carles, Cristina Saura, E. Elez Fernandez, Enriqueta Felip, Jordi Rodon, Judit Matito, Ana Vivancos, Paolo Nuciforo, Ginevra Caratu, Ana Oaknin, T. Macarulla Mercade, Francesco M. Mancuso, J. Tabernero, Roberta Fasani, M. Alsina Maqueda
Publikováno v:
Annals of Oncology. 30:v810-v811
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71f791dd918cc5e13b3a8cbb6c4be943
https://doi.org/10.1093/annonc/mdz269.044
https://doi.org/10.1093/annonc/mdz269.044
Autor:
Cinta Hierro, R. Berché, E. Elez Fernandez, Juan Martin-Liberal, Eva Muñoz-Couselo, Analia Azaro, Enriqueta Felip, Rodrigo Dienstmann, Joan Carles, Javier Ros, Mafalda Oliveira, I. Matos Garcia, Irene Brana, Elena Garralda, P. Prieto, M. Vieito Villar, Cristina Viaplana, I. Gardeazabal, J. Tabernero, O. Saavedra
Publikováno v:
Annals of Oncology. 30:v42
Background Life expectancy longer than 12 weeks(w) is a common inclusion criteria for most Ph1. Despite the presence of several prognostic indeces in drug development, their value for patient selection in clinical trials is not well established. VIO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3d4194ce45958fec1d4a3c1124ff21
https://doi.org/10.1093/annonc/mdz239.046
https://doi.org/10.1093/annonc/mdz239.046
Autor:
J. Garcia-Corbacho, M. Español Rego, R. Cabezón, Jorge Aparicio, Miquel Lozano, Carlos Fernández-Martos, Juan Maurel, E. Elez Fernandez, A. Ruiz Casado, Jessica Cid, X. García de Albéniz, Nohra Cecilia Rodríguez, D. Benitez Ribas, Pilar Escudero, A. Ginés, V. Alonso, L. Bianchi
Publikováno v:
Annals of Oncology. 29:viii203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5766f85f5b1b922043b3e7d9fa25bd66
https://doi.org/10.1093/annonc/mdy281.156
https://doi.org/10.1093/annonc/mdy281.156
Autor:
R. Laeufle, J. Tabernero, R. Debenedetto, Scott Kopetz, Rolf Bruns, J. Straub, Giorgio Massimini, Dirk Arnold, R. Linke, E. Elez Fernandez
Publikováno v:
Annals of Oncology. 29:viii164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e00660f6fe1d15b1ab62ed8f2a396dd5
https://doi.org/10.1093/annonc/mdy281.035
https://doi.org/10.1093/annonc/mdy281.035